Figure 3From: Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age Kaplan-Meier analysis of GBM patient survival for Pro, Mes, and ProMes GBM patients according to age. GBM patients suffering from Pro, Mes, and ProMes tumours do not survive any better if younger than age 40 than identically gene expression-classified GBM patients older than the age of 40.Back to article page